Literature DB >> 13034453

Use of adjuvants in studies on influenza immunization. III. Degree of persistence of antibody in human subjects two years after vaccination.

J E SALK, M CONTAKOS, A M LAURENT, M SORENSEN, A J RAPALSKI, I H SIMMONS, H SANDBERG.   

Abstract

Entities:  

Keywords:  ANTIGENS AND ANTIBODIES; INFLUENZA/immunology

Mesh：

Substances：

Year:  1953        PMID： 13034453     DOI： 10.1001/jama.1953.02940140013005

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  16 in total

1.  A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.

Authors:  R W HOWELL; A N STOTT
Journal:  Br J Ind Med       Date:  1964-10

2.  FIELD TRIALS OF ADJUVANT AND SALINE INFLUENZA VACCINES.

Authors:  W J HERBERT; S SELWYN; J R PHILP
Journal:  Br J Prev Soc Med       Date:  1965-04

3.  Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule.

Authors:  A V HENNESSY; F M DAVENPORT
Journal:  Public Health Rep       Date:  1961-05       Impact factor: 2.792

4.  ANTIBODY responses and clinical reactions with saline and oil adjuvant influenza virus vaccines.

Authors: 
Journal:  Br Med J       Date:  1955-11-19

5.  [Virus diseases in otorhinolaryngology region].

Authors:  R HAAS
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1955-05-02

6.  Active immunization against poliomyelitis.

Authors:  H R COX
Journal:  Bull N Y Acad Med       Date:  1953-12

7.  Epidemiological studies on influenza in familial and general population groups. I. Preliminary report on studies with adjuvant vaccines.

Authors:  R N PHILIP; J A BELL; D J DAVIS; M O BEEM; P M BEIGELMAN
Journal:  Am J Public Health Nations Health       Date:  1954-01

8.  Immunization against poliomyelitis.

Authors:  T E BOYD
Journal:  Bacteriol Rev       Date:  1953-12

9.  Active immunization against poliomyelitis. April 2, 1953.

Authors:  H R Cox
Journal:  J Urban Health       Date:  1998-09       Impact factor: 3.671

Review 10.  A rational, systematic approach for the development of vaccine formulations.

Authors:  Garry L Morefield
Journal:  AAPS J       Date:  2011-02-23       Impact factor: 4.009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.